Interactions Between Nitric Oxide and Lipid Oxidation Pathways
- 19 January 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 88 (1) , 12-21
- https://doi.org/10.1161/01.res.88.1.12
Abstract
—Nitric oxide (·NO) signaling pathways and lipid oxidation reactions are of central importance in both the maintenance of vascular homeostasis and the progression of vascular disease. Because both of these pathways involve free radical species that can also react together at extremely fast rates, convergent interactions between these pathways are expected. Biochemical and cell biology studies have defined multiple interactions of ·NO with oxidizing lipids that could lead to either vascular protection or potentiation of inflammatory vascular injury. For example, low levels of ·NO generated by endothelial nitric oxide synthase can terminate propagating lipid radicals and inhibit lipoxygenases, reactions that would be protective. Alternatively, if generated at elevated levels, for example, after inducible nitric oxide synthase expression in inflammation, ·NO can be converted to prooxidant species, such as peroxynitrite (ONOO–) and nitrogen dioxide (·NO2), that can potentiate inflammatory injury to vascular cells. Finally, both enzymatic and nonenzymatic lipid oxidation reactions can influence ·NO bioactivity by directly scavenging ·NO or altering the induction and catalytic activity of nitric oxide synthase enzymes. In this review, we summarize the biochemical interactions between ·NO and lipid oxidation reactions and discuss the recognized and potential roles of these reactions in the vasculature.Keywords
This publication has 119 references indexed in Scilit:
- Catalytic Consumption of Nitric Oxide by Prostaglandin H Synthase-1 Regulates Platelet FunctionPublished by Elsevier ,2000
- DIFFERENTIAL EFFECTS OF SOME CELL SIGNALLING INHIBITORS UPON NITRIC OXIDE SYNTHASE EXPRESSION AND NUCLEAR FACTOR-κB ACTIVATION INDUCED BY LIPOPOLYSACCHARIDE IN RAT AORTIC SMOOTH MUSCLE CELLSPharmacological Research, 1999
- Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.Heart, 1995
- Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.Journal of Clinical Investigation, 1994
- Selective Inhibition of the 12-Lipoxygenase Pathway of Arachidonic Acid Metabolism by L-Arginine or Sodium Nitroprusside in Intact Human PlateletsBiochemical and Biophysical Research Communications, 1994
- Absolute UV cross sections of methyl and ethyl peroxy radicalsThe Journal of Physical Chemistry, 1992
- Prostaglandin endoperoxide synthase: regulation of enzyme expressionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Prostaglandin endoperoxide synthase: structure and catalysisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Increase in 12-lipoxygenase activity in platelets of spontaneously hypertensive ratsBiochemical and Biophysical Research Communications, 1985